We are live on
!
Find out more
ACP
Ashfield Capital Partners Portfolio holdings
AUM
$1.19B
1-Year Est. Return
14.56%
This Fund
S&P 500
This Quarter
Est. Return
+8.1%
1 Year Est. Return
-14.56%
3 Year Est. Return
+48.8%
5 Year Est. Return
+97.38%
10 Year Est. Return
–
AUM
$777M
AUM Growth
+$30.8M
(+4.1%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-2.81%
Top 10 Holdings %
Top 10 Hldgs %
24.59%
Holding
259
New
11
Increased
48
Reduced
131
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$1.69M |
| 2 |
Global X Lithium & Battery Tech ETF
LIT
|
+$1.54M |
| 3 |
Illumina
ILMN
|
+$1.52M |
| 4 |
Caterpillar
CAT
|
+$1.2M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$999K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.69M |
| 2 |
Microsoft
MSFT
|
+$1.47M |
| 3 |
Alerian MLP ETF
AMLP
|
+$1.29M |
| 4 |
GSK
GSK
|
+$1.28M |
| 5 |
BSCH
Guggenheim BulletShares 2017 Corporate Bond ETF
BSCH
|
+$1.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.38% |
| 2 | Healthcare | 17.23% |
| 3 | Industrials | 10.76% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Communication Services | 8.33% |
Similar funds
MCM
DWM
H6H
SIM
AIL
CL
CCP
RIG
Ashfield Capital Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Ashfield Capital Partners held 259 positions worth $777M, up 4.1% from $747M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ashfield Capital Partners's Q4 2017 filing shows 11 new, 48 increased, 131 reduced and 9 closed positions. Its largest new stake was Global X Lithium & Battery Tech ETF: 39,106 shares worth $1.52M. The largest sale was Apple, an estimated $1.69M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.
- Ashfield Capital Partners's largest Q4 2017 buy was Global X Lithium & Battery Tech ETF: 39,106 shares worth $1.52M.
- Ashfield Capital Partners added most to Praxair Inc in Q4 2017, an estimated $1.69M increase.
- Ashfield Capital Partners's biggest Q4 2017 reduction was Apple, cutting an estimated $1.69M.
- Ashfield Capital Partners fully exited GSK in Q4 2017, selling an estimated $1.28M.
- Ashfield Capital Partners's ten largest holdings make up 25% of its $777M portfolio in Q4 2017.
- Ashfield Capital Partners opened 11 new positions and closed 9 in Q4 2017.
- Ashfield Capital Partners's portfolio value rose 4.1% quarter-over-quarter to $777M.
Based on Ashfield Capital Partners's 13F filing for Q4 2017, filed 13 Feb 2018.